Skip to main content
All products sold for laboratory research purposes only. Not for human or veterinary use.
Unconditional free shipping — every order, nationwide

GLP-2 T

Dual-receptor incretin class agonist studied in metabolic-pathway research.

GLP-2 T is the catalog designation for a synthetic analog in the dual-agonist incretin class — compounds engineered to activate both the GIP and GLP-1 receptors from a single molecule. The dual-receptor approach emerged from the observation that the two incretin pathways interact synergistically in glucose regulation and energy balance.

Research interest centers on how simultaneous receptor engagement changes downstream signaling compared with single-receptor agonism: insulin secretion dynamics, adipose tissue effects, and hypothalamic feeding circuits all respond differently to the dual profile. The class generated some of the most cited metabolic research of recent years.

As with all coded incretin-class compounds in this catalog, GLP-2 T ships lyophilized with full HPLC documentation, for laboratory research use only.

Research use only. Everything on this page describes laboratory research. This compound is supplied strictly for in-vitro research use; it is not approved by the FDA for human or veterinary use, and nothing here is a protocol or a recommendation.

Published research

  • Tirzepatide Once Weekly for the Treatment of Obesity
    Jastreboff AM, et al. N Engl J Med. 2022.PubMed
  • Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
    Frías JP, et al. N Engl J Med. 2021.PubMed

Further reading in the lab library

Researchers also ordered

Browse the catalog